Advanced search
Publication Cover
Leukemia & Lymphoma Volume 54, 2013 - Issue 4
Submit an article Journal homepage
128
Views
3
CrossRef citations to date
0
Altmetric
Letter

Autologous stem cell transplant in human immunodeficiency virus-positive patients with lymphoid malignancies: focus on infectious complications

Ewelina MorawaWeill Cornell Medical College – New York Presbyterian Hospital, New York, NY, USACorrespondence[email protected]
,
Peter MartinWeill Cornell Medical College – New York Presbyterian Hospital, New York, NY, USA
,
Usama GergisWeill Cornell Medical College – New York Presbyterian Hospital, New York, NY, USA
,
Koen van BesienWeill Cornell Medical College – New York Presbyterian Hospital, New York, NY, USA
&
Tsiporah ShoreWeill Cornell Medical College – New York Presbyterian Hospital, New York, NY, USA
Pages 885-888 | Received 25 May 2012, Accepted 13 Aug 2012, Published online: 08 Sep 2012

References

  • Vose JM, Rizzo D, Tao-Wu J, . Autologous transplantation for diffuse aggressive non-Hodgkin lymphoma in first relapse or second remission. Biol Blood Marrow Transplant 2004;10:116–127.
  • Milpied N, Deconinck E, Gaillard F, . Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support. N Engl J Med 2004;350:1287–1295.
  • Balsalobre P, Diez-Martin J, Re A, . Autologous stem-cell transplantation in patients with HIV-related lymphoma. J Clin Oncol 2009;27:2192–2198.
  • Stiff PJ, Unger JM, Cook J, . Randomized phase III US/Canadian intergroup trial (SWOOG S9704) comparing CHOP +/2 R for eight cycles to CHOP +/2 R for six cycles followed by autotransplant for patients with high intermediate or high IPI grade diffuse aggressive non-Hodgkin's lymphoma. J Clin Oncol 2011;29(Suppl.): Abstract 8001.
  • Philip T, Guglielmi C, Hagenbeek A, . Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 1995;333:1540–1545.
  • Krishnan A, Molina A, Zaia J, . Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas. Blood 2005;105:874–878.
  • Re A, Cattaneo C, Michieli M, . High-dose therapy and autologous peripheral-blood stem-cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy. J Clin Oncol 2003;21:4423–4427.
  • Diez-Martin JL, Balsalobre P, Re A, . Comparable survival between HIV+ and HIV-non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation. Blood 2009;113:6011–6014.
  • Re A, Michieli M, Casari S, . High-dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for AIDS-related lymphoma: long-term results of the Italian Cooperative Group on AIDS and Tumors (GICAT) study with analysis of prognostic factors. Blood 2009;114:1306–1313.
  • Fung HC, Stein A, Slovak ML, . A long-term follow-up report on allogeneic stem cell transplantation for patients with primary refractory acute myelogenous leukemia: impact of cytogenetic characteristics on transplantation outcome. Biol Blood Marrow Transplant 2003;9:766–771.
  • Michieli M, Mazzucalo M, Tirelli U, . Stem cell transplantation for lymphoma patients with HIV infection. Cell Transplant 2011;20: 351–370.
  • Krishnan A, Molina A, Zaia J, . Autologous stem cell transplantation for HIV-associated lymphoma. Blood 2001;98:3857–3859.
  • Molina A, Krishnan A, Nadamanee A, . High dose therapy and autologous stem cell transplantation for human immundeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy. Cancer 2000;89:680–689.
  • Spitzer TR, Ambinder RF, Lee JY, . Dose-reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus-associated lymphoma: AIDS Malignancy Consortium study 020. Biol Blood Marrow Transplant 2008;14:59–66.
  • Gabarre J, Marcelin AG, Azar N, . High-dose therapy plus autologous hematopoietic stem cell transplantation for human immunodeficiency virus (HIV)-related lymphoma: results and impact on HIV disease. Haematologica 2004;89:1100–1108.
  • Fassas ABT, Bolaños-Meade J, Buddharaju LN, . Cytomegalovirus infection and non-neutropenic fever after autologous stem cell transplantation: high rates of reactivation in patients with multiple myeloma and lymphoma. Br J Haematol 2001;112:237–241.
  • Kline J, Pollyea DA, Stock W, . Pre-transplant ganciclovir and post transplant high-dose valacyclovir reduce CMV infections after alemtuzumab-based conditioning. Bone Marrow Transplant 2006;37:307–310.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.